Investor Presentaiton

Strong track record Unique model Large moat Significant opportunity Compounding growth Royalty Pharma is the leader in royalty transactions Biopharma royalty market size and share by transaction value, 2012-2022 YTD (1) $10bn 21% 26% $8bn 7% $15bn 83% 53% <$250m $250-500m Royalty Pharma #2 royalty buyer Other royalty buyer >$500m Royalty Pharma has maintained ~60% overall share since 2012 and is the go-to partner for larger transactions ROYALTY PHARMA 1. Internal estimates of historical biopharma royalty market size based on announced transactions; size of blocks are relative to total announced value in each deal size range. 16

View entire presentation